MMP9 and cancer: These results taken together with immunohistochemical staining of the same cancer areas for total and active MMP-9, suggested divergence between enzyme distribution and activity, either because MMP-9 is present mainly in its latent forms in most encapsulated PTCs, or because the active form is inhibited by endogenous antagonists.